TRANSPORT SCIENTIFIQUE MEDICAL
keyboard_backspaceBack to HomeContact
6 rue Robert Schwint - ZAC de l'échange
25770 CHEMAUDIN ET VAUX
France
DAF
About us
Partner of the French Blood Establishment for more than 30 years, and of the main regional health facilities, Transport Scientifique Medical has real expertise in his activity : The sensitive goods transport at temperature directed or ventilated.
(labile blood products, medical biology samples, cellular and tissue products (grafts, stem cell, placental blood, CAR-T, etc.), pharmaceutical products and goods, etc.)
With a real flexibility towards our customers, we can respond to any unexpected changes as soon as possible
Business offer
- Regular transport of temperature sensitive goods (ambient, fresh, frozen) or ventilated (Dry-shipper)
- On-demand and dedicated transport of temperature sensitive goods (ambient, fresh, frozen) or ventilated (Dry-shipper)
Activities
- Service
- Cardiology
- Genetic Diseases
- Oncology
- Nervous Central System
- Hematology
- Infectiology
- Immunology
- Ophthalmology
- Inflammation
- Other
- CMC
- Master Cell Bank
- Storage
- Bioproduction
- Batch release
- Storage matter
- Instruction
- Logistic
- Formulation
- Delivery
- Route of Administration
- Devices associated
- Clinical trials
- Phase I
- Phase II
- Phase III
- Phase IV
- Cell origin
- Cell Banking
- IPs
- MSC
- CD34 + HSC cells
- Bioproduction engineering
- Delivery
- Transport
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Adoptive T Cell Major Challenges in Solid Tumors
- Delivery/homing
- Cell procurement
- Autologous
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Supply chain logistics
- Monitoring logistics
- Vaccine delivery/Administration routes
- Delivery/ Encapsulation
- Polymeric Nanoparticles
- Lipid Nanoparticles
- Nano emulsions
- Adjuvanted delivery systems
- Clinical trials
- Phase I
- Phase II (human challenge trials)
- Phase III (large population pending pathogen prevalence)
- Vaccine shipment and distribution
- Cold chain logistics
- Post-market surveillance
- Clinical Trial phase IV